NCT07545655

Brief Summary

This study shows that in craniotomy patients using a skull pin head holder, an ultrasound-guided scalp block reduces perioperative opioid consumption, improves hemodynamic stability, and decreases the inflammatory response.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
10mo left

Started Apr 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Apr 2026Mar 2027

First Submitted

Initial submission to the registry

February 18, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

April 10, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 22, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2027

Expected
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2027

Last Updated

April 22, 2026

Status Verified

March 1, 2026

Enrollment Period

10 months

First QC Date

February 18, 2026

Last Update Submit

April 21, 2026

Conditions

Keywords

CraniotomyUltrasound-guided scalp blockSkull pin head holderPerioperative opioid consumptionHemodynamic stabilityInflammatory response

Outcome Measures

Primary Outcomes (1)

  • Total opioid consumption within 24 hours postoperatively (morphine milligram equivalents, mg)

    All opioid analgesics administered within 24 hours postoperatively will be converted to morphine milligram equivalents (mg) for each participant. The outcome will be reported as a single total value per participant.

    0-24 hours postoperatively

Secondary Outcomes (6)

  • Mean resting pain score at 24 hours postoperatively measured using the Numeric Rating Scale (0-10)

    24 hours postoperatively

  • Mean arterial pressure during pin head holder placement (mmHg)

    Perioperative/Periprocedural

  • Mean systemic immune-inflammation index at 24 hours postoperatively

    24 hours postoperatively

  • Mean systemic inflammation response index at 24 hours postoperatively

    24 hours postoperatively

  • Number of participants requiring rescue analgesia within 24 hours postoperatively

    0-24 hours postoperatively

  • +1 more secondary outcomes

Study Arms (2)

patient who scalp block applied

Patients who receive an ultrasound-guided preoperative scalp block before skull pin placement and surgical incision

patient without scalp block applied

Patients who do not receive a scalp block and instead undergo local infiltration anesthesia performed by the surgical team before skull pin placement and surgical incision

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients aged 18 years and older who are scheduled for elective intracranial surgery under general anesthesia with planned skull pin head holder (Mayfield-type) fixation, classified as American Society of Anesthesiologists (ASA) physical status I-III, and who have provided informed consent will be included.

You may qualify if:

  • Aged 18 years and older
  • Scheduled for elective intracranial surgery with skull pin head holder fixation
  • Classified as American Society of Anesthesiologists (ASA) physical status I-III
  • Provided written informed consent in the preoperative period

You may not qualify if:

  • Allergy to local anesthetics
  • Coagulopathy or anticoagulant use
  • Local infection at injection site
  • Pregnancy or breastfeeding
  • Chronic opioid use (\>3 months) or chronic pain syndrome
  • Severe psychiatric disorders affecting pain assessment
  • Emergency surgery
  • Active infection or rheumatic disease
  • Hematological disease or malignancy (active or within 5 years)
  • Recent use of biological agents, chemotherapy, or corticosteroids (within 30 days)
  • NSAID use within 24 hours before surgery
  • Advanced organ failure (NYHA III-IV, Child-Pugh C, eGFR \<30 mL/min)
  • Refusal to participate
  • Communication difficulties preventing pain assessment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fatih Sultan Mehmet Training and Research Hospital

Istanbul, ataşehir, 34752, Turkey (Türkiye)

Location

Related Publications (3)

  • Teymourian H, Besarati A, Azizifarsani H, Rostami P, Tafrishinejad A, Tafrishinejad R. Navigating scalp nerve blocks: A comparative study of ultrasound vs. landmark methods. Agri. 2025 Oct;37(4):191-200. doi: 10.14744/agri.2025.49358.

  • Li B, Cao Z, Huang J, Chen Y, Li Z, Wu W, Li C, Qiu T, Chen J. Effect of ultrasound-guided scalp nerve block on hemodynamics and postoperative agitation in hypertensive cerebral hemorrhage craniotomy patients: a prospective randomized controlled study. Front Neurol. 2026 Jan 14;16:1721992. doi: 10.3389/fneur.2025.1721992. eCollection 2025.

  • Yang X, Ma J, Li K, Chen L, Dong R, Lu Y, Zhang Z, Peng M. A comparison of effects of scalp nerve block and local anesthetic infiltration on inflammatory response, hemodynamic response, and postoperative pain in patients undergoing craniotomy for cerebral aneurysms: a randomized controlled trial. BMC Anesthesiol. 2019 Jun 1;19(1):91. doi: 10.1186/s12871-019-0760-4.

Study Officials

  • arzu yıldırım ar, prof

    Fatih Sultan Mehmet Training and Research Hospital

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident doctor

Study Record Dates

First Submitted

February 18, 2026

First Posted

April 22, 2026

Study Start

April 10, 2026

Primary Completion (Estimated)

February 10, 2027

Study Completion (Estimated)

March 10, 2027

Last Updated

April 22, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations